Literature DB >> 10675799

Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease.

F Crawford1, L Abdullah, J Schinka, Z Suo, M Gold, R Duara, M Mullan.   

Abstract

Epidemiological studies have demonstrated that risk factors for vascular disease are also risk factors for Alzheimer's disease (AD). The gene for the angiotensin converting enzyme (ACE) has recently been reported to be associated with risk for AD. We have investigated the possibility of such an association in 98 clinic-based and 73 community-based AD cases versus 175 community-based controls and find a gender-specific association of ACE genotype with AD in the female clinic population. These data suggest that gender may interact with genetic factors to influence risk for AD. Gender-specific risk for AD has been previously reported, and a biological rationale for involvement of ACE in the AD process is supported by studies exploring the relationship between AD and vascular risk factors such as hypertension. However, the results may also be a consequence of the known anomalies that arise in genetic association studies as a consequence of sample selection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675799     DOI: 10.1016/s0304-3940(00)00791-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Angiotensin-converting enzyme genotype affects skeletal muscle strength in elite athletes.

Authors:  Aldo Matos Costa; António José Silva; Nuno Garrido; Hugo Louro; Daniel Almeida Marinho; Mário Cardoso Marques; Luiza Breitenfeld
Journal:  J Sports Sci Med       Date:  2009-09-01       Impact factor: 2.988

2.  Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel.

Authors:  S D Israeli-Korn; M Masarwa; E Schechtman; A Abuful; R Strugatsky; S Avni; L A Farrer; R P Friedland; R Inzelberg
Journal:  Neuroepidemiology       Date:  2009-12-11       Impact factor: 3.282

3.  Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China.

Authors:  Fang Yuan; Lu-Shun Zhang; Hong-Yu Li; Miao Liao; Meili Lv; Chongjie Zhang
Journal:  DNA Cell Biol       Date:  2013-04-09       Impact factor: 3.311

4.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

5.  Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.

Authors:  Xiao-Yu Xin; Ze-Hua Lai; Kai-Qi Ding; Li-Li Zeng; Jian-Fang Ma
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 6.  Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine.

Authors:  Marina A Lynch
Journal:  Front Aging Neurosci       Date:  2022-03-31       Impact factor: 5.750

7.  Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer's type in an elderly Arab population in Wadi Ara, Israel.

Authors:  Abdalla Bowirrat; Jing Cui; Kristin Waraska; Robert P Friedland; Marlene Oscar-Berman; Lindsay A Farrer; Amos Korczyn; Clinton T Baldwin
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

8.  Identification of Novel Alzheimer's Disease Loci Using Sex-Specific Family-Based Association Analysis of Whole-Genome Sequence Data.

Authors:  Dmitry Prokopenko; Julian Hecker; Rory Kirchner; Brad A Chapman; Oliver Hoffman; Kristina Mullin; Winston Hide; Lars Bertram; Nan Laird; Dawn L DeMeo; Christoph Lange; Rudolph E Tanzi
Journal:  Sci Rep       Date:  2020-03-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.